SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011719
Filing Date
2023-05-01
Accepted
2023-05-01 06:20:52
Documents
19
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A acrx20221231_10ka.htm   iXBRL 10-K/A 555446
2 EXHIBIT 4.7 ex_507994.htm EX-4.7 120543
3 EXHIBIT 10.20 ex_507997.htm EX-10.20 420046
4 EXHIBIT 10.21 ex_507995.htm EX-10.21 96045
5 EXHIBIT 10.23 ex_507996.htm EX-10.23 23416
6 EXHIBIT 31.1 ex_507998.htm EX-31.1 3300
7 EXHIBIT 31.2 ex_507999.htm EX-31.2 3093
  Complete submission text file 0001437749-23-011719.txt   1588298

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA acrx-20221231.xsd EX-101.SCH 3601
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20221231_def.xml EX-101.DEF 16773
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20221231_lab.xml EX-101.LAB 22725
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20221231_pre.xml EX-101.PRE 17699
13 EXTRACTED XBRL INSTANCE DOCUMENT acrx20221231_10ka_htm.xml XML 7446
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 23869801
SIC: 2834 Pharmaceutical Preparations